On or around 07/06/2018 (Date of order of distribution of settlement)
Filing Date: September 19, 2016
According to the law firm press release, the lawsuit alleges throughout the Class Period Misonix made false and/or misleading statements and/or failed to disclose that: (1) deficiencies existed in Misonix’s internal controls over financial reporting; and (2) as a result, Defendants’ statements about Misonix’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
On March 24, 2017, the Court issued an Order appointing Lead Plaintiffs and Counsel.
On June 23, 2017, the parties entered into a Stipulation of Settlement. The Court granted preliminary approval of the Settlement on September 7 and entered Final Judgment on December 16. On July 6, 2018, the Court issued an Order granting Plaintiffs' Motion for Disbursement of Funds.
Company & Securities Information
Defendant: Misonix, Inc.
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: MSON
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.